Publicaciones en colaboración con investigadores/as de McMaster University (24)

2019

  1. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

    Thrombosis Journal, Vol. 17, Núm. 1

2017

  1. Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study

    Journal of Pediatrics, Vol. 184, pp. 209-214.e1

2016

  1. Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials

    PLoS Medicine, Vol. 13, Núm. 6

  2. Planning and reporting of quality-of-life outcomes in cancer trials

    Annals of Oncology

  3. Premature discontinuation of randomized trials in critical and emergency care: A retrospective cohort study

    Critical Care Medicine, Vol. 44, Núm. 1, pp. 130-137

2015

  1. Completion and publication rates of randomized controlled trials in surgery: An empirical study

    Annals of Surgery, Vol. 262, Núm. 1, pp. 68-73

  2. Efficiency of pragmatic search strategies to update clinical guidelines recommendations

    BMC Medical Research Methodology, Vol. 15, Núm. 1

  3. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7

2014

  1. Prevalence, characteristics, and publication of discontinued randomized trials

    JAMA, Vol. 311, Núm. 10, pp. 1045-1051

2013

  1. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

    Trials, Vol. 14, Núm. 1

2012

  1. Learning from failure - Rationale and design for a study about discontinuation of randomized trials (DISCO study)

    BMC Medical Research Methodology, Vol. 12

  2. Use and interpretation of composite end points in orthopaedic trials

    Journal of Bone and Joint Surgery, Vol. 94, Núm. SUPPL. 1, pp. 65-69

2010

  1. Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis

    JAMA, Vol. 303, Núm. 12, pp. 1180-1187

2009

  1. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: Systematic review and meta-regression analysis

    BMJ (Online), Vol. 338, Núm. 7693

  2. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials

    Annals of Internal Medicine

  3. Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

    Trials, Vol. 10

2008

  1. Author reply: the master-question: meta-analyses and stopped-early randomized trials-a problem?

    Journal of Clinical Epidemiology

2007

  1. Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: A systematic review

    European Heart Journal, Vol. 28, Núm. 4, pp. 469-477

  2. Composite endpoints in clinical trials: the trees and the forest

    Journal of Clinical Epidemiology

  3. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns

    Journal of Clinical Epidemiology